Given the observed downregulation of miR-129 in gastric adenocarcinoma and its inverse correlation with systemic inflammatory and metabolic markers (CEA, CA 19-9, LDH, and CRP), we further explored whether these alterations extend beyond tumor biology to affect vascular and neurological function. The gene discussed is CRP; the disease is neoplasm.